Annual ROE
-108.64%
0.00%
01 December 2023
Summary:
Cadrenal Therapeutics Common Stock annual return on equity is currently -108.64%CVKD annual ROE is now at all-time high.CVKD ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-142.95%
-49.24%-52.55%
01 September 2024
Summary:
Cadrenal Therapeutics Common Stock quarterly return on equity is currently -142.95%, with the most recent change of -49.24% (-52.55%) on 01 September 2024. Over the past year, it has increased by +133.52% (+48.29%). CVKD quarterly ROE is now -117.79% below its all-time high of 803.48%, reached on 31 March 2023.CVKD Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CVKD ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +48.3% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
CVKD ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | at low | -117.8% | +97.5% |
| 5 y | 5 years | at high | at low | -117.8% | +97.5% |
| alltime | all time | at high | at low | -117.8% | +97.5% |
Cadrenal Therapeutics Common Stock ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -142.95%(+52.5%) |
| June 2024 | - | -93.71%(+24.7%) |
| Mar 2024 | - | -75.13%(-46.8%) |
| Dec 2023 | -108.64% | -141.17%(-48.9%) |
| Sept 2023 | - | -276.47%(-95.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | -5645.86%(-802.7%) |
| Mar 2023 | - | 803.48%(+1062.8%) |
| Dec 2022 | - | 69.10%(-62.5%) |
| Sept 2022 | - | 184.24%(+82.1%) |
| June 2022 | - | 101.18% |
FAQ
- What is Cadrenal Therapeutics Common Stock annual return on equity?
- What is the all time high annual ROE for Cadrenal Therapeutics Common Stock?
- What is Cadrenal Therapeutics Common Stock quarterly return on equity?
- What is the all time high quarterly ROE for Cadrenal Therapeutics Common Stock?
- What is Cadrenal Therapeutics Common Stock quarterly ROE year-on-year change?
What is Cadrenal Therapeutics Common Stock annual return on equity?
The current annual ROE of CVKD is -108.64%
What is the all time high annual ROE for Cadrenal Therapeutics Common Stock?
Cadrenal Therapeutics Common Stock all-time high annual return on equity is -108.64%
What is Cadrenal Therapeutics Common Stock quarterly return on equity?
The current quarterly ROE of CVKD is -142.95%
What is the all time high quarterly ROE for Cadrenal Therapeutics Common Stock?
Cadrenal Therapeutics Common Stock all-time high quarterly return on equity is 803.48%
What is Cadrenal Therapeutics Common Stock quarterly ROE year-on-year change?
Over the past year, CVKD quarterly return on equity has changed by +133.52% (+48.29%)